Sagimet Biosciences Inc.
SGMT
$6.22
$0.142.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 116.69M | 125.41M | 144.57M | 151.25M | 152.49M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.29M | 996.00K | 615.00K | 1.06M | 4.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 500.00K | 793.00K | 888.00K | 463.00K | 407.00K |
| Total Current Assets | 119.48M | 127.20M | 146.07M | 152.77M | 157.19M |
|
|
|||||
| Total Current Assets | 119.48M | 127.20M | 146.07M | 152.77M | 157.19M |
| Net Property, Plant & Equipment | 115.00K | 152.00K | 38.00K | 77.00K | 114.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 62.00K | -- | -- |
| Total Assets | 128.40M | 137.41M | 146.17M | 160.26M | 174.78M |
|
|
|||||
| Total Accounts Payable | 4.24M | 1.92M | 3.22M | 1.43M | 1.15M |
| Total Accrued Expenses | 4.78M | 5.17M | 3.86M | 2.95M | 2.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 115.00K | 152.00K | 39.00K | 78.00K | 116.00K |
| Total Finance Division Other Current Liabilities | 8.00K | 1.00K | 63.00K | 5.00K | 11.00K |
| Total Other Current Liabilities | 8.00K | 1.00K | 63.00K | 5.00K | 11.00K |
| Total Current Liabilities | 9.15M | 7.25M | 7.18M | 4.45M | 4.09M |
|
|
|||||
| Total Current Liabilities | 9.15M | 7.25M | 7.18M | 4.45M | 4.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.15M | 7.25M | 7.18M | 4.45M | 4.09M |
|
|
|||||
| Common Stock & APIC | 455.92M | 453.96M | 452.36M | 450.89M | 449.35M |
| Retained Earnings | -336.78M | -323.87M | -313.49M | -295.31M | -279.11M |
| Treasury Stock & Other | 117.00K | 76.00K | 121.00K | 230.00K | 441.00K |
| Total Common Equity | 119.26M | 130.16M | 138.99M | 155.81M | 170.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 119.26M | 130.16M | 138.99M | 155.81M | 170.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 119.26M | 130.16M | 138.99M | 155.81M | 170.68M |
|
|
|||||